The independent source for health policy research, polling, and news.
4,401 - 4,420 of 15,263 Results
With U.S. cases skyrocketing, demand for Gilead’s dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients.
The number of adults seeking to get inoculated has risen since December, according to a new poll.
Carmela Coyle, who represents California’s hospitals in the state Capitol, is a power player whose clout has grown during the pandemic. Though she hasn’t won every battle, she has helped shape the state’s response to the crisis.
As President Biden calls for more support to help schools hold in-person classes, public health experts say schools can be relatively safe if they take well-known steps to prevent covid. But a KHN investigation shows many districts and states have ignored health advice or written their own questionable safety rules for schools.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Corporations like Starbucks, Honeywell, Microsoft, Costco and Google are lining up to help with vaccine logistics. But the problem of the moment is supply, not systems.
Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn’t overcome vast obstacles.
Thousands of people died shortly after inoculation, but their deaths weren’t related to getting a vaccine.
The ability of California health officials to multitask in a pandemic will be severely tested as they scramble to find staff for vaccination sites while maintaining testing and contact tracing.
Hospitals dealing with staff shortages during the current covid surge are unable to tap into one valuable resource: foreign-trained doctors, nurses and other health workers, many with experience treating infectious diseases. Colorado, Massachusetts, New Jersey, New York and Nevada are the only states to have eased credentialing requirements during the pandemic.
Those walking away free were facing years in prison for crimes of “unbounded greed.”
KHN has teamed up with PolitiFact to track what becomes of President Joe Biden’s 2020 campaign promises over the next four years. As he moves into the West Wing, what are his chances of making progress on health care?
Nearly 6 in 10 people 65 and older say they don’t have enough information about how to get vaccinated, according to a new KFF poll.
President Joe Biden is wasting no time getting to work. On his first day in office, Biden signed a series of executive orders addressing the covid pandemic, promising more to come. But even with Democrats taking the barest majority in the Senate, the new president’s ambitious proposals on covid and other health issues could be in for a rough ride. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read too.
All kinds of new structures are popping up to extend the outdoor dining season. Some are safer than others.
It's time-consuming but worthwhile: Residents respond to messages about Covid testing and vaccines when outreach teams speak their language and make a personal connection.
In late December, then-President Donald Trump signed a law that eliminates — only for people with Lou Gehrig’s disease — the required five-month waiting period before benefits begin under the Social Security Disability Insurance program. Gaining SSDI also gives these patients immediate Medicare health coverage.
On health care, President Joe Biden made it clear that combating the covid-19 pandemic will be his top priority. “We must set aside politics and finally face this pandemic as one nation,” he said. “We will get through this together.”
As covid patients flood California emergency rooms, hospitals are increasingly desperate to find enough staffers to care for them all. But some nurses worry hospitals will use the pandemic as an excuse to permanently roll back their hard-won nurse-patient ratios.
Months after President Donald Trump credited monoclonal antibody therapy for his quick recovery from covid-19, only a trickle of the product has found its way into regular people. While hundreds of thousands of vials sit unused, sick patients who might benefit from early treatment have been left on their own to vie for access.
© 2026 KFF